SPY408.32+8.23 2.06%
DIA327.10+4.32 1.34%
IXIC11,984.52+321.73 2.76%

--Guggenheim Adjusts Eli Lilly's Price Target to $333 From $292, Reiterates Buy Rating

MT Newswires · 05/02/2022 05:41

Please log in to view news